Pluristem Therapeutics Inc (PSTI)

[FDApproved]

Last week, ICL Open unveiled a collaboration with Pluri to pioneer advanced bioactive carriers and biostimulants. This partnership aims to leverage natural delivery mechanisms within plants, boosting crop yields and fostering sustainability in agriculture.

"Pluri's unique cell line manufacturing technology is ideal for such development, and the marriage with ICL's mineral and biological plant nutrition solutions holds promise for a breakthrough in this field," ICL wrote on its LinkedIn page. "The resultant technological platform is expected to produce multiple novel plant nutrition solutions in the future."

https://www.jpost.com/business-and-innovation/article-783632